| Date Filed | Type | Description |
| 07/05/2023 |
4
| Kramer Robin (Chief Accounting Officer) has filed a Form 4 on BIOGEN INC.|
Txns:
| Paid exercise price by delivering 122 shares
@ $284.85, valued at
$34.8k
Exercised 252 restricted stock units
@ $0 |
|
| 02/22/2023 |
4
| Kramer Robin (Chief Accounting Officer) has filed a Form 4 on BIOGEN INC.|
Txns:
| Paid exercise price by delivering 238 shares
@ $278.38, valued at
$66.3k
Exercised 512 restricted stock units
@ $0
Disposed of 454 restricted stock units
@ $0 |
|
| 02/14/2023 |
4
| Kramer Robin (Chief Accounting Officer) has filed a Form 4 on BIOGEN INC.|
Txns:
| Paid exercise price by delivering 262 shares
@ $286.3, valued at
$75k
Paid exercise price by delivering 67 shares
@ $286.3, valued at
$19.2k
Paid exercise price by delivering 261 shares
@ $286.3, valued at
$74.7k
Exercised 833 restricted stock units
@ $0
Exercised 228 restricted stock units
@ $0
Disposed of 278 restricted stock units
@ $0 |
|
| 02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2023 |
4
| Kramer Robin (Chief Accounting Officer) has filed a Form 4 on BIOGEN INC.|
Txns:
| Granted 887 shares
@ $0 |
|
| 12/12/2022 |
4
| Kramer Robin (Chief Accounting Officer) has filed a Form 4 on BIOGEN INC.|
Txns:
| Paid exercise price by delivering 156 shares
@ $289.1, valued at
$45.1k
Exercised 350 restricted stock units
@ $0 |
|
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/15/2022 |
4
| Kramer Robin (Director) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Granted 33,000 options to buy
@ $5.11, valued at
$168.6k
|
|
| 02/23/2022 |
4
| Kramer Robin (Chief Accounting Officer) has filed a Form 4 on BIOGEN INC.|
Txns:
| Paid exercise price by delivering 117 shares
@ $209.79, valued at
$24.5k
Exercised 396 restricted stock units
@ $0
Disposed of 570 restricted stock units
@ $0 |
|
| 02/15/2022 |
4
| Kramer Robin (Chief Accounting Officer) has filed a Form 4 on BIOGEN INC.|
Txns:
| Paid exercise price by delivering 35 shares
@ $214.59, valued at
$7.5k
Paid exercise price by delivering 51 shares
@ $214.59, valued at
$10.9k
Paid exercise price by delivering 85 shares
@ $214.59, valued at
$18.2k
Exercised 99 restricted stock units
@ $0
Disposed of 189 restricted stock units
@ $0
Exercised 176 restricted stock units
@ $0
Disposed of 326 restricted stock units
@ $0 |
|
| 02/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/21/2022 |
4
| Kramer Robin (Chief Accounting Officer) has filed a Form 4 on BIOGEN INC.|
Txns:
| Granted 244 shares
@ $0 |
|
| 12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2020 |
4
| Kramer Robin (Director) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Granted 30,000 options to buy
@ $3.15, valued at
$94.5k
|
|
| 12/09/2020 |
3
| Kramer Robin (Director) has filed a Form 3 on Armata Pharmaceuticals, Inc. |
| 12/07/2020 |
4
| Kramer Robin (VP, Chief Accounting Officer) has filed a Form 4 on BIOGEN INC.|
Txns:
| Paid exercise price by delivering 22 shares
@ $244.09, valued at
$5.4k
Exercised 74 restricted stock units
@ $0
Disposed of 102 restricted stock units
@ $0 |
|
| 07/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2019 |
4
| Kramer Robin (VP, Chief Accounting Officer) has filed a Form 4 on BIOGEN INC.|
Txns:
| Paid exercise price by delivering 25 shares
@ $290.7, valued at
$7.3k
Exercised 84 restricted stock units
@ $0
Disposed of 92 restricted stock units
@ $0 |
|
| 02/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2018 |
4
| Kramer Robin (VP, Chief Accounting Officer) has filed a Form 4 on BIOGEN INC.|
Txns:
| Granted 530 restricted stock units
@ $0
Granted 265 restricted stock units
@ $0 |
|
| 11/19/2018 |
3
| Kramer Robin (VP, Chief Accounting Officer) has filed a Form 3 on BIOGEN INC. |
| 05/01/2018 |
4
| Kramer Robin (Sr VP Chief Accounting Officer) has filed a Form 4 on HERTZ GLOBAL HOLDINGS, INC|
Txns:
| Paid exercise price by delivering 195 shares
@ $21.94, valued at
$4.3k
Exercised 798 rights
@ $0 |
|
| 03/12/2018 |
4
| Kramer Robin (Sr VP Chief Accounting Officer) has filed a Form 4 on HERTZ GLOBAL HOLDINGS, INC|
Txns:
| Sold 5,450 shares
@ $19.67, valued at
$107.2k
|
|
| 03/06/2018 |
4
| Kramer Robin (Sr. VP, Chief Acc Officer) has filed a Form 4 on HERTZ GLOBAL HOLDINGS, INC|
Txns:
| Paid exercise price by delivering 357 shares
@ $18.69, valued at
$6.7k
Paid exercise price by delivering 3,237 shares
@ $18.69, valued at
$60.5k
Exercised 1,201 restricted stock units
@ $0
Granted 7,846 options to buy
@ $17.73, valued at
$139.1k
Acquired 13,302 rights
@ $0 |
|
| 09/15/2017 |
4
| Kramer Robin (Sr VP, ChiefAccountingOfficer) has filed a Form 4 on HERTZ GLOBAL HOLDINGS, INC|
Txns:
| Sold 3,524 shares
@ $21.5331, valued at
$75.9k
|
|
| 05/16/2017 |
4
| Kramer Robin (Sr VP, ChiefAccountingOfficer) has filed a Form 4 on HERTZ GLOBAL HOLDINGS, INC|
Txns:
| Paid exercise price by delivering 497 shares
@ $10.69, valued at
$5.3k
|
|
| 04/06/2017 |
4
| Kramer Robin (Sr VP, ChiefAccountingOfficer) has filed a Form 4 on HERTZ GLOBAL HOLDINGS, INC |
| 06/08/2016 |
3
| Kramer Robin (Sr VP, ChiefAccountingOfficer) has filed a Form 3 on Hertz Rental Car Holding Company, Inc. |
|